Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fundraising
Biotech
Fierce Biotech Fundraising Tracker: Granite, Etiome a & more
Welcome to Fierce Biotech's Fundraising Tracker for 2025.
Gabrielle Masson
,
Darren Incorvaia
Apr 24, 2025 8:00am
Etiome emerges with $50M from Flagship, plans to preempt disease
Apr 24, 2025 6:00am
Glycomine's $115M series C to fund genetic disorder ph. 2 plans
Apr 16, 2025 9:20am
AIRNA preps for clinical test with $155M series B
Apr 1, 2025 7:00am
Eye disease biotech looks to clinical trials with $93M series B
Mar 25, 2025 8:00am
Arbor sails into rocky gene editing waters with $74M
Mar 18, 2025 6:30am